Medicxi Ventures (UK) Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
14
- Investments
-
92
- Portfolio
-
26
- Exits
-
47
Medicxi Ventures (UK) General Information
Company Description
Founded in 2016, Medicxi is a venture capital investment firm based in London, United Kingdom. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in healthcare, life sciences, and technology-based sectors in Europe.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- 25 Great Pulteney Street
- London W1F 9LT
- England, United Kingdom
Medicxi Ventures (UK) Investments (92)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Vaderis Therapeutics | 11-Aug-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Fore Biotherapeutics | 08-Jul-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Ethyreal Bio | 10-Jun-2026 | Biotechnology | Pre-Clinical Trials | |||
| Altesa BioSciences | 19-Feb-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| D3 Bio | 09-Dec-2025 | Biotechnology | Generating Revenue | |||
| Curevo Vaccine | 06-Mar-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| RAPT Therapeutics | 27-Dec-2024 | Drug Discovery | Generating Revenue | |||
| Ottimo Pharma | 19-Dec-2024 | Drug Discovery | Generating Revenue | |||
| ViceBio | 23-Sep-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| D3 Bio | 08-Apr-2024 | Early Stage VC | Biotechnology | Generating Revenue |
Medicxi Ventures (UK) Exits (47)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Vimela Therapeutics | 30-Jun-2026 | Bankruptcy: Liquidation | |
| Curevo Vaccine | 26-May-2026 | ||
| RAPT Therapeutics | 03-Mar-2026 | ||
| ViceBio | 04-Dec-2025 | ||
| RAPT Therapeutics | 23-Oct-2025 | ||
| Monopteros Therapeutics | 13-Jul-2025 | ||
| Critical Pressure | 19-May-2025 | ||
| Yukin Therapeutics | 06-Dec-2024 | ||
| Kymo Therapeutics | 16-Jul-2024 | Out of Business | |
| Divide & Conquer | 02-Jul-2024 | Out of Business |
Medicxi Ventures (UK) Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Medicxi Ventures (UK) Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Medicxi Ventures (UK) Co-Investors (70)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| OrbiMed | 5 |
|
|
||
| Avoro Capital |
|
|
|||
| Janus Henderson Investors |
|
|
|||
| RA Capital Management |
|
|
|||
| HBM Healthcare Investments |
|
|
Medicxi Ventures (UK) FAQs
-
What is Medicxi Ventures (UK)?
Founded in 2016, Medicxi is a venture capital investment firm based in London, United Kingdom.
-
When was Medicxi Ventures (UK) founded?
Medicxi Ventures (UK) was founded in 2016.
-
Where is Medicxi Ventures (UK) headquartered?
Medicxi Ventures (UK) is headquartered in London, United Kingdom.
-
What is Medicxi Ventures (UK)'s total asset value?
Medicxi Ventures (UK) has around in total assets under management.
-
How many investments has Medicxi Ventures (UK) made?
Medicxi Ventures (UK) has made 92 investments.
-
What has Medicxi Ventures (UK) invested in?
Medicxi Ventures (UK) has made numerous investments in companies like Vaderis Therapeutics, Fore Biotherapeutics, and Ethyreal Bio within the Drug Discovery and Biotechnology industries.
-
What has Medicxi Ventures (UK) invested in recently?
Medicxi Ventures (UK)'s latest investment was on 11-Aug-2026 in Vaderis Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
